<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151447">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02035189</url>
  </required_header>
  <id_info>
    <org_study_id>202342</org_study_id>
    <nct_id>NCT02035189</nct_id>
  </id_info>
  <brief_title>Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients</brief_title>
  <official_title>Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients and Its Performance as an Adjunct in the Diagnosis and Prognostication of Infectious Processes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study in evaluating the clinical impact of procalcitonin on the care of
      Stem cell transplant recipient and its performance as an adjunct in the diagnosis and
      prognostication of Infectious processes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall goal of this project will be to provide new insights into the use of biomarkers
      in surveillance for infectious processes in Stem Cell Transplant recipients by evaluating
      the added impact of procalcitonin testing on detection of infectious processes
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Levels of Procalcitonin</measure>
    <time_frame>Daily up to 30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Levels of Procalcitonin will be measured daily for a period not to exceed 30 days.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Multiple Myeloma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Multiple Myeloma at UAMS receiving Stem Cell transplantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients age 18-95 years with Multiple Myeloma (MM) undergoing stem cell
             transplantation

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Senu Apewokin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Naveen Sanathkumar, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Senu Apewokin, MD</last_name>
    <phone>5015266990</phone>
    <email>skapewokin@uams.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Naveen Sanathkumar, MD, MHSA</last_name>
    <phone>5016811972</phone>
    <email>nsanathkumar@uams.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naveen Sanathkumar, MD</last_name>
      <phone>501-681-1972</phone>
      <email>nsanathkumar@uams.edu</email>
    </contact>
    <contact_backup>
      <last_name>Senu Apewokin, MD</last_name>
      <phone>5015266990</phone>
      <email>skapewokin@uams.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Senu Apewokin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Naveen Sanathkumar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monica Grazziutti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anupam Pande, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Susanibar Adaniya, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 10, 2014</lastchanged_date>
  <firstreceived_date>January 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
